The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for BH Norman


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
12
Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1.EBI
Eli Lilly
9
Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain.EBI
Eli Lilly
12
Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors.EBI
Eli Lilly
11
Identification of potent and selective retinoic acid receptor gamma (RAR¿) antagonists for the treatment of osteoarthritis pain using structure based drug design.EBI
Eli Lilly
20
Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors.EBI
Eli Lilly
1
Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146.EBI
Eli Lilly
7
Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency.EBI
Monsanto
4
Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1).EBI
Eli Lilly
21
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1).EBI
Eli Lilly
15
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.EBI
Norman Drug Discovery Training and Consulting
14
Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design.EBI
Lilly Research Laboratories
24
Prolyl hydroxylase inhibitors and methods of useBDB
Akebia Therapeutics
79
Benzazepine dicarboxamide compoundsBDB
Hoffmann-La Roche
48
Drugs for treating respiratory diseasesBDB
Daiichi Sankyo
24
Inhibitor Bound Crystal Structures of Bacterial Nitric Oxide Synthase.BDB
University of California Irvine
40
SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.BDB
Instituto De Quimica Medica (Csic)
28
First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.BDB
Instituto De Quimica Medica (Csic)